These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 24508135

  • 1. Rugulactone derivatives act as inhibitors of NF-κB activation and modulates the transcription of NF-κB dependent genes in MDA-MB-231cells.
    Mohapatra DK, Reddy DS, Ramaiah MJ, Ghosh S, Pothula V, Lunavath S, Thomas S, Valli SN, Bhadra MP, Yadav JS.
    Bioorg Med Chem Lett; 2014 Mar 01; 24(5):1389-96. PubMed ID: 24508135
    [Abstract] [Full Text] [Related]

  • 2. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA, Mehmi I, Atlas E, Colomer R, Lupu R.
    Int J Oncol; 2004 Mar 01; 24(3):591-608. PubMed ID: 14767544
    [Abstract] [Full Text] [Related]

  • 3. PDCD6 additively cooperates with anti-cancer drugs through activation of NF-κB pathways.
    Park SH, Lee JH, Lee GB, Byun HJ, Kim BR, Park CY, Kim HB, Rho SB.
    Cell Signal; 2012 Mar 01; 24(3):726-33. PubMed ID: 22142513
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Histone deacetylase inhibition down-regulates cyclin D1 transcription by inhibiting nuclear factor-kappaB/p65 DNA binding.
    Hu J, Colburn NH.
    Mol Cancer Res; 2005 Feb 01; 3(2):100-9. PubMed ID: 15755876
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Quinacrine has anticancer activity in breast cancer cells through inhibition of topoisomerase activity.
    Preet R, Mohapatra P, Mohanty S, Sahu SK, Choudhuri T, Wyatt MD, Kundu CN.
    Int J Cancer; 2012 Apr 01; 130(7):1660-70. PubMed ID: 21544805
    [Abstract] [Full Text] [Related]

  • 10. Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells.
    Chinni SR, Li Y, Upadhyay S, Koppolu PK, Sarkar FH.
    Oncogene; 2001 May 24; 20(23):2927-36. PubMed ID: 11420705
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation.
    Ozaki I, Zhang H, Mizuta T, Ide Y, Eguchi Y, Yasutake T, Sakamaki T, Pestell RG, Yamamoto K.
    Clin Cancer Res; 2007 Apr 01; 13(7):2236-45. PubMed ID: 17404108
    [Abstract] [Full Text] [Related]

  • 13. Rugosin E, an ellagitannin, inhibits MDA-MB-231 human breast cancer cell proliferation and induces apoptosis by inhibiting nuclear factor-kappaB signaling pathway.
    Kuo PL, Hsu YL, Lin TC, Tzeng WS, Chen YY, Lin CC.
    Cancer Lett; 2007 Apr 18; 248(2):280-91. PubMed ID: 16963181
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of NF-kappaB-mediated transcription and induction of apoptosis by melampolides and repandolides.
    Ma G, Khan SI, Benavides G, Schühly W, Fischer NH, Khan IA, Pasco DS.
    Cancer Chemother Pharmacol; 2007 Jun 18; 60(1):35-43. PubMed ID: 17149609
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Swainsonine inhibits growth and potentiates the cytotoxic effect of paclitaxel in hepatocellular carcinoma in vitro and in vivo.
    You N, Liu W, Wang T, Ji R, Wang X, Gong Z, Dou K, Tao K.
    Oncol Rep; 2012 Dec 18; 28(6):2091-100. PubMed ID: 22993037
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Induction of apoptosis by Bigelovii A through inhibition of NF‑κB activity.
    Guan F, Shan Y, Wang Q, Wang M, Chen Y, Yin M, Liu F, Zhao Y, Zhang J, Feng X.
    Mol Med Rep; 2018 Aug 18; 18(2):1600-1608. PubMed ID: 29901099
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.